These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
244 related items for PubMed ID: 10778510
1. [The evaluation of the effects of pharmacological treatment of children with attention deficit hyperactivity disorder]. Roselló B, Amado L, Presentación MJ. Rev Neurol; 1999 Feb; 28 Suppl 2():S177-82. PubMed ID: 10778510 [Abstract] [Full Text] [Related]
2. [The effects of psychostimulants on the cognitive results and behaviour of children with the combined subtype of attention deficit with hyperactivity]. Mulas F, Roselló B, Morant A, Hernández S, Pitarch I. Rev Neurol; 1999 Feb; 35(1):17-24. PubMed ID: 12389187 [Abstract] [Full Text] [Related]
3. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit]. Bricard C, Boidein F. Encephale; 2001 Feb; 27(5):435-43. PubMed ID: 11760693 [Abstract] [Full Text] [Related]
4. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder. Pae CU. Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730 [No Abstract] [Full Text] [Related]
5. Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresis. Golubchik P, Weizman A. Psychosomatics; 2009 Jun 30; 50(2):178. PubMed ID: 19377031 [No Abstract] [Full Text] [Related]
6. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Foy JM, Earls MF. Pediatrics; 2005 Jan 30; 115(1):e97-104. PubMed ID: 15629972 [Abstract] [Full Text] [Related]
7. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study. Huang YS, Guilleminault C, Li HY, Yang CM, Wu YY, Chen NH. Sleep Med; 2007 Jan 30; 8(1):18-30. PubMed ID: 17157069 [Abstract] [Full Text] [Related]
8. A novel multidomain computerized cognitive assessment for attention-deficit hyperactivity disorder: evidence for widespread and circumscribed cognitive deficits. Leitner Y, Doniger GM, Barak R, Simon ES, Hausdorff JM. J Child Neurol; 2007 Mar 30; 22(3):264-76. PubMed ID: 17621495 [Abstract] [Full Text] [Related]
9. Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate. Gadow KD, Sverd J. Adv Neurol; 2006 Mar 30; 99():197-207. PubMed ID: 16536367 [No Abstract] [Full Text] [Related]
10. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder. Lee SI, Hong SD, Kim SY, Kim EJ, Kim JH, Kim JH, Park MK, Park S, Park JH, Oh EY, Lim TS, Cheong S, Cho IH, Choi JW. Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):210-6. PubMed ID: 17046131 [Abstract] [Full Text] [Related]
11. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study. Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P. Child Care Health Dev; 2006 Sep 30; 32(5):575-83. PubMed ID: 16919137 [Abstract] [Full Text] [Related]
12. The acceptability of interventions for attention-deficit hyperactivity disorder among elementary and middle school teachers. Power TJ, Hess LE, Bennett DS. J Dev Behav Pediatr; 1995 Aug 30; 16(4):238-43. PubMed ID: 7593658 [Abstract] [Full Text] [Related]
13. Psychostimulants in preschool children with attention-deficit/hyperactivity disorder: clinical evidence from a developmental disorders institution. Ghuman JK, Ginsburg GS, Subramaniam G, Ghuman HS, Kau AS, Riddle MA. J Am Acad Child Adolesc Psychiatry; 2001 May 30; 40(5):516-24. PubMed ID: 11349695 [Abstract] [Full Text] [Related]
14. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample. Yang P, Hsu HY, Chiou SS, Chao MC. Aust N Z J Psychiatry; 2007 Dec 30; 41(12):998-1004. PubMed ID: 17999272 [Abstract] [Full Text] [Related]
15. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Research Units on Pediatric Psychopharmacology Autism Network. Arch Gen Psychiatry; 2005 Nov 30; 62(11):1266-74. PubMed ID: 16275814 [Abstract] [Full Text] [Related]
16. The effects of methylphenidate on word decoding accuracy in boys with attention-deficit/hyperactivity disorder. Bental B, Tirosh E. J Clin Psychopharmacol; 2008 Feb 30; 28(1):89-92. PubMed ID: 18204348 [Abstract] [Full Text] [Related]
17. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder. Polanczyk G, Zeni C, Genro JP, Guimarães AP, Roman T, Hutz MH, Rohde LA. Arch Gen Psychiatry; 2007 Feb 30; 64(2):218-24. PubMed ID: 17283289 [Abstract] [Full Text] [Related]
18. [Central stimulants in the treatment of children with ADHD: unknown long-term effect and uncertain pharmacological documentation]. Zetterström R. Lakartidningen; 2002 Feb 14; 99(7):677-80. PubMed ID: 11887717 [No Abstract] [Full Text] [Related]
19. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment]. Oberpichler-Schwenk H. Med Monatsschr Pharm; 2006 Nov 14; 29(11):415-6. PubMed ID: 17131689 [No Abstract] [Full Text] [Related]
20. [Methylphenidate (Ritalin) treatment in attention deficit hyperactivity disorder]. Shalev R, Gross-Tsur V. Harefuah; 1997 May 01; 132(9):672-5. PubMed ID: 9225587 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]